Health

Current Picks

Lung Cancer Screening Uptake Drops After US Medicare Low-Dose CT Reimbursement Cuts

By Elena Vargas / Jun 8, 2026

Medicare's 2024 cut to low-dose CT reimbursement led to a 20–30% drop in lung cancer screening. Experts disagree on the evidence, raising concerns about delayed diagnoses and excess deaths.

UK NHS Breast Cancer Screening Interval Debate Splits Epidemiologists on Harms

By Elena Vargas / Jun 8, 2026

The UK NHS screens women for breast cancer every three years, but a growing debate among epidemiologists questions whether a shorter interval would save more lives or increase harms like overdiagnosis.

Japanese Sleep Apnoea Patients Wait Eighteen Months for CPAP Devices

By Esther Okello / Jun 8, 2026

Japan's CPAP waiting list stretches 18–24 months, among the longest in the OECD. Patients ration use or buy second-hand machines. Experts call for home testing and regulatory reform.

US Medicare Limits CBT Sessions for Depression Despite Trial Evidence

By Esther Okello / Jun 8, 2026

Medicare caps CBT at 8 sessions per year for depression, but clinical trials show 16–20 sessions produce better outcomes. This gap affects millions of older adults.

Ugandan Coal Miners Test Positive for Silicosis Five Years Before Screening Guidelines Recommend

By Min Park / Jun 8, 2026

Ugandan artisanal coal miners in Kasese develop silicosis after just 5–7 years of exposure, yet screening guidelines still recommend starting at 10 years. This feature examines the evidence, the clinical gap, and what a pragmatic shift could look like.

US Obesity Drug Prescribing Splits Experts on Long-Term Metabolic Reversal

By Min Park / Jun 8, 2026

GLP-1 drugs like semaglutide and tirzepatide reshape obesity care, but experts disagree on whether they achieve long-term metabolic reversal. The access divide further complicates outcomes.

Brazil Public Chemotherapy Reimbursement Caps Delay First-Line Prostate Cancer Care

By Min Park / Jun 8, 2026

Brazil’s SUS reimbursement caps on abiraterone and enzalutamide delay first-line prostate cancer treatment, leading to disease progression and worse outcomes. Evidence from São Paulo and policy reform options examined.

Mongolian Ger District Bedsits Fuel Asthma as Coal Smoke Seeps Through Winter

By Elena Vargas / Jun 8, 2026

In Ulaanbaatar's ger districts, coal smoke from stoves in felt tents drives winter PM2.5 above 1,000 µg/m³. Experts disagree on the asthma link, but children bear the burden.

UK Depression Waiting Lists Push Patients to Online CBT Without Therapist Support

By Raphael Andriamanjato / Jun 8, 2026

Long NHS waiting lists for depression therapy are pushing patients toward online CBT without therapist support. This article examines the evidence, patient experiences, and what GPs wish commissioners understood.

Dengue Vaccine Efficacy Splits Experts in Sri Lanka as Serotype Mismatch Worsens

By Elena Vargas / Jun 8, 2026

Sri Lanka's dengue vaccine program faces expert division as serotype mismatch reduces efficacy. Two camps of epidemiologists debate the evidence amid rising cases.

US Private Insurance Formulary Tiers Delay Generic Statins for Younger Heart Patients

By Elena Vargas / Jun 8, 2026

Private insurance formularies often place generic statins on high tiers, leading to costly co-pays and delays for younger heart patients. This gap between evidence and insurance design undermines preventive care.

Penicillin Allergy De-Labeling Protocols Stall in UK Emergency Departments

By Min Park / Jun 8, 2026

Despite evidence that over 90% of penicillin allergy labels are inaccurate, de-labeling protocols remain underused in UK emergency departments, fueling antibiotic resistance and patient harm.

Depression Medication Stockouts Force Kenyan Patients to Cycle Through Five Regimens

By Esther Okello / Jun 8, 2026

In Kenya, antidepressant stockouts force patients like Grace Anyango to switch medications repeatedly, undermining treatment and eroding trust in mental health care.

Indian ASHA Workers Track Birth Weights Without Functional Weighing Scales

By Elena Vargas / Jun 8, 2026

In rural India, ASHA workers often lack functioning scales to weigh newborns, leading to unreliable data and missed referrals for low birth weight infants.

India HPV Vaccine Stockouts Delay Cervical Cancer Catch-Up for Girls Aged Nine

By Esther Okello / Jun 8, 2026

India's HPV vaccine stockouts disrupt catch-up drives for nine-year-old girls, delaying cervical cancer prevention. Experts debate single-dose strategy amid supply bottlenecks.

South African Gold Miners Diagnosed with Silicosis Decades After Dust Exposure Rules

By Elena Vargas / Jun 8, 2026

Decades after dust limits were set, South African gold miners still develop silicosis. This feature examines the clinical-practice gap: evidence supports screening, but few miners are diagnosed in time.

UK NHS Regional Formularies Block First-Line Biologics for Severe Asthma Patients

By Elena Vargas / Jun 8, 2026

Regional NHS formularies in England delay access to first-line biologics for severe asthma, leading to worse outcomes and a postcode lottery despite NICE approval.

Maternal Sepsis Protocols Reduce Deaths But Miss One in Five US Cases

By Min Park / Jun 8, 2026

Standardized maternal sepsis bundles have cut deaths in the US, but roughly one in five cases still evade early detection. The debate over protocol rigidity versus clinical judgment continues.

US Methicillin-Resistant Staph Infections Plateau as Outpatient Antibiotic Stewardship Lags

By Min Park / Jun 8, 2026

Invasive MRSA rates have plateaued in the US after a decade of decline, yet outpatient antibiotic prescribing remains high. Learn how stewardship gaps, diagnostic delays, and stalled vaccines sustain the threat.

Imported Fluoroquinolone Antibiotics Sold Loose at South African Corner Shops Fuel Resistant UTIs

By Elena Vargas / Jun 8, 2026

Loose fluoroquinolone antibiotics sold without prescription at South African corner shops are driving resistant urinary tract infections, with ciprofloxacin resistance exceeding 50% in some communities.